Baltimore Early Phase Clinical Unit (EPCU) — Baltimore, Maryland

Baltimore Early Phase Clinical Unit (EPCU) is a clinical research site located in Baltimore, Maryland, United States 21225.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Baltimore Early Phase Clinical Unit (EPCU) has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Bond Avillion 2 Development LP.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baltimore Early Phase Clinical Unit (EPCU)?

Baltimore Early Phase Clinical Unit (EPCU) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baltimore Early Phase Clinical Unit (EPCU) conducted?

Baltimore Early Phase Clinical Unit (EPCU) has 1 clinical trials on record. Their work covers Asthma.

Is Baltimore Early Phase Clinical Unit (EPCU) accredited by Crixeo Health?

Baltimore Early Phase Clinical Unit (EPCU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baltimore Early Phase Clinical Unit (EPCU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.